Dear Investor,
The global peptide therapeutics market is set to more than double — from $42B to $117B by 2034.
And one company is positioned at the front of the pack.
This Company isn’t just selling peptides — they’ve built an entire medical-grade platform around them.
Their model?
→ Doctor-led protocols
→ AI-powered optimization
→ Concierge delivery direct to consumer
This isn’t science fiction. It’s already generating revenue across North America, Europe, and the Middle East.
And it’s backed by a dream team: Saudi royalty, private equity pros, and elite biohackers like Gary Brecka.
While the market focuses on drugs like Ozempic... Vesalius is going after the broader opportunity: total body optimization.
This could be the most compelling longevity play of the year.
Subscribe now and discover why early investors are paying attention.
By submitting your email address, you give Trading Whisperer permission to deliver the presentation or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to our stock alerts newsletter, Trading Whisperer. You can unsubscribe at any time. Privacy Policy
Trading Whisperer
We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security.
We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of Vesalius Longevity Labs, Inc. The compensation consists of up to $6,000 and was received/will be received from Market Jar Media.
This compensation should not be considered as an endorsement of the securities of adviser Vesalius Longevity Labs, Inc. and we are not responsible for any errors or omissions in any information provided about the securities of Vesalius Longevity Labs, Inc. by Trading Whisperer or Market Jar Media.
We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions.
This disclosure is made as of 05/25/2025.
Tidak ada komentar:
Posting Komentar